BACKGROUND: Hyperintensities in the splenium of the corpus callosum (CCS) have been proposed as a radiographic diagnostic criterion for fragile X-associated tremor ataxia syndrome (FXTAS). METHODS: Magnetic resonance images from patients with FXTAS and from nonpremutation carriers with movement disorders were viewed by a radiologist who was blinded to gene status, and radiographic criteria for FXTAS were scored. Phenotypic data used for diagnosis of FXTAS also were collected. RESULTS: Twenty-two patients with FXTAS and 23 controls were included. Hyperintensity in the CCS (the CCS sign) was more common in men with FXTAS versus controls (87% vs. 40%) but not in women with FXTAS (100% vs. 50% in controls). The CCS sign had higher sensitivity compared with the middle cerebellar peduncle sign (white matter lesions in middle cerebellar peduncle) in both men (0.87 vs. 0.67) and women (1 vs. 0.29) with FXTAS, but it had lower specificity in both men (0.6 vs. 0.8) and women (0.5 vs. 1). CONCLUSIONS: The CCS sign is common in patients with FXTAS, but it is not significantly more prevalent in women with FXTAS compared with controls. This may be due to small sample sizes in the current study. Other signs, such as brainstem white matter disease, were more common in women with FXTAS and differed from those in men with FXTAS. This finding suggests that additional studies evaluating the diagnostic criteria for FXTAS need to be conducted, ideally with neuropathological confirmation of the disease.
BACKGROUND: Hyperintensities in the splenium of the corpus callosum (CCS) have been proposed as a radiographic diagnostic criterion for fragile X-associated tremor ataxia syndrome (FXTAS). METHODS: Magnetic resonance images from patients with FXTAS and from nonpremutation carriers with movement disorders were viewed by a radiologist who was blinded to gene status, and radiographic criteria for FXTAS were scored. Phenotypic data used for diagnosis of FXTAS also were collected. RESULTS: Twenty-two patients with FXTAS and 23 controls were included. Hyperintensity in the CCS (the CCS sign) was more common in men with FXTAS versus controls (87% vs. 40%) but not in women with FXTAS (100% vs. 50% in controls). The CCS sign had higher sensitivity compared with the middle cerebellar peduncle sign (white matter lesions in middle cerebellar peduncle) in both men (0.87 vs. 0.67) and women (1 vs. 0.29) with FXTAS, but it had lower specificity in both men (0.6 vs. 0.8) and women (0.5 vs. 1). CONCLUSIONS: The CCS sign is common in patients with FXTAS, but it is not significantly more prevalent in women with FXTAS compared with controls. This may be due to small sample sizes in the current study. Other signs, such as brainstem white matter disease, were more common in women with FXTAS and differed from those in men with FXTAS. This finding suggests that additional studies evaluating the diagnostic criteria for FXTAS need to be conducted, ideally with neuropathological confirmation of the disease.
Entities:
Keywords:
fragile X mental retardation 1 (FMR1); fragile X‐associated tremor ataxia syndrome; magnetic resonance imaging; middle cerebellar peduncle; splenium of the corpus callosum
Authors: Danuta Z Loesch; Lucas Litewka; Peter Brotchie; Richard M Huggins; Flora Tassone; Mark Cook Journal: Ann Neurol Date: 2005-08 Impact factor: 10.422
Authors: Nicola Moscufo; Leslie Wolfson; Dominik Meier; Maria Liguori; Peter G Hildenbrand; Dorothy Wakefield; Julia A Schmidt; Godfrey D Pearlson; Charles R G Guttmann Journal: Age (Dordr) Date: 2011-04-20
Authors: Caroline J Moore; Eileen M Daly; Flora Tassone; Carolyn Tysoe; Nicole Schmitz; Virginia Ng; Xavier Chitnis; Philip McGuire; John Suckling; Kay E Davies; Randi J Hagerman; Paul J Hagerman; Kieran C Murphy; Declan G M Murphy Journal: Brain Date: 2004-10-13 Impact factor: 13.501
Authors: J S Adams; P E Adams; D Nguyen; J A Brunberg; F Tassone; W Zhang; K Koldewyn; S M Rivera; J Grigsby; L Zhang; C DeCarli; P J Hagerman; R J Hagerman Journal: Neurology Date: 2007-08-28 Impact factor: 9.910
Authors: Sébastien Jacquemont; Randi J Hagerman; Maureen A Leehey; Deborah A Hall; Richard A Levine; James A Brunberg; Lin Zhang; Tristan Jardini; Louise W Gane; Susan W Harris; Kristin Herman; James Grigsby; Claudia M Greco; Elizabeth Berry-Kravis; Flora Tassone; Paul J Hagerman Journal: JAMA Date: 2004-01-28 Impact factor: 56.272
Authors: Jun Yi Wang; David Hessl; Andrea Schneider; Flora Tassone; Randi J Hagerman; Susan M Rivera Journal: JAMA Neurol Date: 2013-08 Impact factor: 18.302
Authors: M A Leehey; E Berry-Kravis; C G Goetz; L Zhang; D A Hall; L Li; C D Rice; R Lara; J Cogswell; A Reynolds; L Gane; S Jacquemont; F Tassone; J Grigsby; R J Hagerman; P J Hagerman Journal: Neurology Date: 2007-12-05 Impact factor: 9.910